PBPC mobilization with paclitaxel, ifosfamide, and G-CSF with or without amifostine: results of a prospective randomized trial
- 1 February 2001
- journal article
- clinical trial
- Published by Wiley in Transfusion
- Vol. 41 (2) , 196-200
- https://doi.org/10.1046/j.1537-2995.2001.41020196.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cellsBone Marrow Transplantation, 1999
- Interferon-α in the idiopathic hypereosinophilic syndrome: consideration of five casesAnnals of Hematology, 1998
- Amifostine stimulates formation of multipotent and erythroid bone marrow progenitorsLeukemia, 1998
- Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancerAnnals of Oncology, 1998
- Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.Journal of Clinical Oncology, 1996
- Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.Journal of Clinical Oncology, 1995
- Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphomaBlood, 1994
- Multiparameter flow-cytometrical quantitation of circulating CD34+-cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony-assayBritish Journal of Haematology, 1991
- High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphomaBlood, 1989
- Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord bloodBlood, 1978